ST-segment elevation resolution in lead aVR: a strong predictor of adverse outcomes in patients with non-ST-segment
Masami Kosuge1, Toshiaki Ebina, Kiyoshi Hibi
1The Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Insights
ST-segment elevation in lead aVR without resolution in non-ST-segment elevation acute coronary syndromes (NSTE-ACS) patients predicts adverse outcomes. This finding highlights aVR ST elevation resolution as a crucial prognostic indicator in NSTE-ACS.
Area of Science:
- Cardiology
- Clinical Medicine
- Diagnostic Electrocardiography
Background:
- The prognostic significance of ST-segment elevation resolution in lead aVR for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) remains incompletely understood.
- Lead aVR electrocardiogram (ECG) findings are increasingly recognized for their role in assessing acute coronary syndromes.
Purpose of the Study:
- To investigate the impact of ST-segment elevation resolution in lead aVR on clinical outcomes in patients diagnosed with NSTE-ACS.
- To determine if ST-segment elevation in lead aVR without subsequent resolution is an independent predictor of adverse events.
Main Methods:
- Electrocardiograms (ECGs) were analyzed on admission and at 6 hours in 367 NSTE-ACS patients.
- ST-segment elevation >or=0.5 mm in lead aVR was considered significant (ST upward arrowaVR).
- ST resolution was defined as >50% reduction in ST elevation in lead aVR from admission to 6 hours.
Main Results:
- 92 patients presented with ST upward arrowaVR; 50 achieved ST resolution.
- ST upward arrowaVR without resolution was linked to older age, greater ST depression in other leads, elevated troponin T, and more extensive coronary artery disease (left main and/or 3-vessel).
- Patients with ST upward arrowaVR without resolution had significantly higher rates of 30-day adverse events, including death, reinfarction, or urgent revascularization (HR 5.62, p=0.018).
Conclusions:
- ST upward arrowaVR without ST resolution is a potent independent predictor of 30-day adverse outcomes in NSTE-ACS patients.
- The absence of ST resolution in lead aVR correlates with the extent and severity of coronary artery disease.
- Monitoring ST-segment resolution in lead aVR offers valuable prognostic information for NSTE-ACS management.
Background:
The impact of ST-segment elevation resolution in lead aVR on outcomes in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) is unclear.
Methods And Results:
Electrocardigrams (ECGs) were recorded on admission and 6 h later in 367 patients with NSTE-ACS. ST-segment deviation >or=0.5 mm was considered significant: 92 patients had ST-segment elevation in lead aVR on admission ECG (ST upward arrowaVR), and 275 did not. Among patients with ST upward arrowaVR, 50 had ST resolution, defined as a reduction >50% in the degree of ST-segment elevation in lead aVR from admission to 6 h later, and 42 did not. ST upward arrowaVR without ST resolution was associated with older age, greater ST-segment depression in other leads on admission and 6 h later, higher rates of positive troponin T, left main and/or 3-vessel coronary disease, and adverse events such as death, (re)infarction, or urgent revascularization within 30 days after admission. Multivariate analysis showed that ST upward arrowaVR without ST resolution was the strongest independent predictor of death or (re)infarction within 30 days after admission (hazard ratio 5.62, p=0.018).
Conclusions:
ST upward arrowaVR without ST resolution is a strong predictor of 30-day adverse outcomes and correlates with the extent and severity of coronary artery disease in patients with NSTE-ACS.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome V: Nursing Management
